UBS Reiterates a 'Buy' on Cardinal Health (CAH); Q1: Drug Distribution to Offset Medical
Tweet Send to a Friend
UBS reiterates a 'Buy' on Cardinal Health (NYSE: CAH), lowers PT from $43 to $41.
UBS analyst says, "CAH is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst says, "CAH is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
